MSSA Doubles Production Capacity for Sodium Methylate
MSSA, part of the International Chemical Investors Group (ICIG), announced the expansion of its sodium methylate production unit at its La Rochelle, France, site.
News
PCI Pharma Services Acquires Ajinomoto Althea
PCI Pharma Services has completed its acquisition of Ajinomoto Althea, a CDMO subsidiary of Ajinomoto.
Roquette Acquires IFF Pharma, Reorganizes into Two Business Groups
Roquette completes IFF Pharma Solutions acquisition and unveils new structure for global growth and innovation.
Cyprumed and MSD Enter Licensing Agreement for Oral Peptide Therapeutics
MSD receives a non-exclusive license for Cyprumed's drug delivery technology for developing oral peptide therapeutics.
Petronas Inaugurates Specialty Chemicals Laboratory in Shanghai
Perstorp and BRB, subsidiaries of Petronas Chemicals Group (PCG), inaugurated an innovation hub in Shanghai, China. The laboratory will support growth in the region by increasing technical support for customers.
Ineos and Covestro Announce Landmark LNG Deal
Ineos and Covestro announced a significant long-term agreement for the natural gas supply for up to eight years, starting in 2027.
Merck & Co. Breaks Ground on $1 Billion Biologics Center in US
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.
Valerie Diele-Braun Leaves IMCD
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.
Merck to Acquire US Biopharma Company SpringWorks Therapeutics
Merck and biopharmaceutical company SpringWorks Therapeutics, have entered into a definitive agreement for Merck to acquire SpringWorks.
Asahi Kasei: Ken Shinomiya Becomes Leader of Asahi Kasei’s Healthcare Sector
Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, to succeed Richard Packer as Head of Healthcare.
Fujifilm Diosynth Biotechnologies & Regeneron Sign Manufacturing Agreement
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced a 10-year manufacturing supply agreement, valued at over $3 billion (€2.64 billion), with Regeneron Pharmaceuticals to provide US-based production of its industry-leading biologic medicines, which treat millions of patients worldwide.
From Innovation to Implementation
What happens when over 300 pharmaceutical leaders from across Europe and beyond gather in Berlin? Insightful discussions, strategic collaboration and opinions exchange — all under one roof. The 5th edition of the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP), held on 14–15 April, brought together decision-makers from across the pharmaceutical value chain to explore the technologies, trends and innovations shaping drug production and packaging.
Roche Invests $50 Billion in Pharmaceuticals & Diagnostics
Roche recently announced that it will invest $50 billion (€43.8 billion) into the United States in the next five years.
Suanfarma Appoints Pere Mañé as New CEO
CDMO Suanfarma appoints Pere Mañé Godina as its new CEO, marking the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion.
BASF Divests Two Joint Ventures in China
BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.
Thermo Fisher Opens Cell Therapy Collaboration Center in San Diego
Thermo Fisher Scientific recently announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, California, US.
Boehringer Ingelheim Leadership Changes
Shashank Deshpande, member of the Board of Managing Directors, has been appointed Chairman of the Board of Managing Directors.
Shilpa Secures SEC, CDSCO Approval for New IND Tablets in NAFLD
Shilpa Medicare has received approval from India’s top drug authorities to move forward with its new IND - Nor-Ursodeoxycholic Acid (500 mg).
AC Biode – Chemical Technology for a more Sustainable Future
AC Biode developed a diverse portfolio of products based on chemical technology designed to provide more sustainable alternatives to conventional practices.
Ineos Inovyn launches 9th Global Award
The awards are designed to recognise pioneering ideas and showcase the vital role vinyl plays.
Cellasto Invests €60 million to Establish Second Plant in China
Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.
Meribel Pharma Solutions Launches
A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions, has launched today with an extensive integrated network across Europe.
Super Sapiens Europe Selects 9 Deep-Tech Start-ups
Scientifica Venture Capital, in collaboration with the Institut des Relations Economiques France-Italie (IREFI), has unveiled the winners of the Super Sapiens Europe initiative.
Asahi Kasei Launches Life Science Division to Boost Bioprocess Innovation
To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure.
Novo Nordisk Invests $1.09 Billion in Brazil
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
Strategic Value Partners and Blantyre Capital Acquire OQ Chemicals
Strategic Value Partners (SVP) and Blantyre Capital Limited (Blantyre) recently announced the acquisition of OQ Chemicals (Oxea), a leading global producer and merchant of oxo chemicals.
Ethris and Lonza to Develop Spray-Dried mRNA Respiratory Vaccines
Ethris and Lonza have teamed up to develop room-temperature stable, spray-dried mRNA vaccines for respiratory diseases. This collaboration aims to create mucosal delivery formulations, offering a promising new approach to combat respiratory illnesses.
Solvay Expands Rare Earths Production in Europe
Solvay has officially inaugurated its rare earths production line for permanent magnets at the La Rochelle facility, marking a significant milestone in the Group’s commitment to meeting Europe’s strategic goals.
Oncodesign Services Appoints Aidan Synnott as CEO
Oncodesign Services has appointed Aidan Synnott as chief executive officer to help strengthen its position as a trusted partner in drug discovery.
Veranova Appoints Scott Zugel as New Global VP
Veranova welcomes Scott Zugel as Global VP of Analytical Research Development Operations.
Boehringer Ingelheim Opens New R&D Center in Basel
NBE Therapeutics (NBE), a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel.
HAS Acquires Cerbios-Pharma
HAS Healthcare Advanced Synthesis (HAS) recently announced the planned acquisition of Cerbios-Pharma (Cerbios), a globally recognized manufacturer of chemical and biological APIs, including antibody-drug conjugates (ADCs).
Ineos Energy Acquires Oil & Gas Assets from CNOOC
The completion of the deal marks the third major investment by Ineos Energy in the USA in the past three years. It increases Ineos' capital spending on energy assets in the USA to above $3 billion.
Covestro to Launch Automated Lab for Coatings and Adhesives Development
New facility will focus on crosslinkers and binders, with the potential to test tens of thousands of formulations per year. Digitalization and automation enable data-driven research and development, while networked robotics allow more efficient data generation for segment-specific application testing.
Ineos Enterprises Sells Ineos Composites to KPS for €1.7 Billion
Ineos Enterprises has completed the sale of its composites business to KPS Capital Partners, LP (“KPS”) for ~€1.7 billion.
